magnus evertson

Lead market research and competitive intelligence activities in Central Nervous System and Cardio Metabolic therapeutic areas for drug pipeline assets. This includes a nearly $5M budget for primary and secondary market research on pre-clinical to phase III clinical trial assets. - Using LSS principles, modernized approach to market assessment by incorporating stronger upfront secondary research, which reduced market assessment research time from 3 months to 1 month, led to higher quality data, and eliminated $300K+ per asset in primary research. - Led primary pipeline asset research projects, including qualitative research such as Target Product Profile, patient, healthcare provider and caretaker journeys, and quantitative research such as Conjoint Analysis. - Strategically planned and secured budget approvals for annual market research activities.

Served as primary point of contact for 50+ high-profile pharmaceutical and biotechnology clients, managing several scientific studies for them, and ensuring that protocols, contracts and test materials were implemented for on-time study starts. - Managed rigid project timelines from protocol design to issuance of final report to successfully meet client and company expectations, and ensure GLP, OECD and ICH requirements were met. - Coordinated data collection to guarantee timely result reporting to the study monitor; also wrote study reports in preparation of individual project and program audits. - Evaluated data to determine cytotoxic and genotoxic effects for variety of in vitro and in vivo GLP and non-GLP genetic toxicology studies.